News

The Pharma Letter6h
FDA delays review of Bayer’s elinzanetant NDA
The US Food and Drug Administration (FDA) has notified Bayer that it has extended the review period for the New Drug ...
The Pharma Letter6h
AstraZeneca’s Cristian Massacesi joins BMS executive team
US pharma major Bristol Myers Squibb revealed it has appointed Dr Cristian Massacesi as executive vice president, chief ...